| Bioactivity | Evuzamitide is a diagnostic imaging agent. Evuzamitide as a pan-amyloid radiotracer binding to amyloid deposits from multiple amyloidogenic proteins. Evuzamitide can be used for the research of early diagnosis of amyloid cardiomyopathy (CMP) and monitoring[1][2]. |
| Name | Evuzamitide |
| CAS | 1420048-58-3 |
| Sequence | Gly-Gly-Gly-Tyr-Ser-Lys-Ala-Gln-Lys-Ala-Gln-Ala-Lys-Gln-Ala-Lys-Gln-Ala-Gln-Lys-Ala-Gln-Lys-Ala-Gln-Ala-Lys-Gln-Ala-Lys-Gln-Ala-Gln-Lys-Ala-Gln-Lys-Ala-Gln-Ala-Lys-Gln-Ala-Lys-Gln |
| Shortening | GGGYSKAQKAQAKQAKQAQKAQKAQAKQAKQAQKAQKAQAKQAKQ |
| Formula | C202H351N71O62 |
| Molar Mass | 4766.39 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Clerc OF, et al. Cardiac Amyloid Quantification Using 124I-Evuzamitide (124I-P5+14) Versus 18F-Florbetapir: A Pilot PET/CT Study. JACC Cardiovasc Imaging. 2023 Nov;16(11):1419-1432. |